BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27571786)

  • 1. Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial).
    Stek C; Schutz C; Blumenthal L; Thienemann F; Buyze J; Nöstlinger C; Ravinetto R; Wouters E; Colebunders R; Maartens G; Wilkinson RJ; Lynen L; Meintjes G
    JMIR Res Protoc; 2016 Aug; 5(3):e173. PubMed ID: 27571786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
    Meintjes G; Stek C; Blumenthal L; Thienemann F; Schutz C; Buyze J; Ravinetto R; van Loen H; Nair A; Jackson A; Colebunders R; Maartens G; Wilkinson RJ; Lynen L;
    N Engl J Med; 2018 Nov; 379(20):1915-1925. PubMed ID: 30428290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisone for the prevention of tuberculosis-associated IRIS (randomized controlled trial): Impact on the health-related quality of life.
    Wouters E; Stek C; Swartz A; Buyze J; Schutz C; Thienemann F; Wilkinson RJ; Meintjes G; Lynen L; Nöstlinger C
    Front Psychol; 2022; 13():983028. PubMed ID: 36275235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tuberculosis-associated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research.
    Walker NF; Stek C; Wasserman S; Wilkinson RJ; Meintjes G
    Curr Opin HIV AIDS; 2018 Nov; 13(6):512-521. PubMed ID: 30124473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in initiating ART among HIV-Infected patients in China-risk factors and management.
    Yang H; Liu Q; Wu Y; He K; Zeng Q; Liu M
    BMC Infect Dis; 2024 Jan; 24(1):5. PubMed ID: 38166781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
    Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
    AIDS; 2013 Oct; 27(16):2577-86. PubMed ID: 24096631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CD4 T cell count and optimal timing of antiretroviral therapy initiation with immune reconstitution inflammatory syndrome and all-cause mortality for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis.
    Li L; Li J; Chai C; Liu T; Li P; Qu M; Zhao H
    Int J Clin Exp Pathol; 2021; 14(6):670-679. PubMed ID: 34239668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome.
    Meintjes G; Wilkinson RJ; Morroni C; Pepper DJ; Rebe K; Rangaka MX; Oni T; Maartens G
    AIDS; 2010 Sep; 24(15):2381-90. PubMed ID: 20808204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of HIV-associated tuberculosis, tuberculosis-IRIS and prednisone on lung function.
    Stek C; Allwood B; Du Bruyn E; Buyze J; Schutz C; Thienemann F; Lombard A; Wilkinson RJ; Meintjes G; Lynen L
    Eur Respir J; 2020 Mar; 55(3):. PubMed ID: 31862762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.
    Luetkemeyer AF; Kendall MA; Nyirenda M; Wu X; Ive P; Benson CA; Andersen JW; Swindells S; Sanne IM; Havlir DV; Kumwenda J;
    J Acquir Immune Defic Syndr; 2014 Apr; 65(4):423-8. PubMed ID: 24226057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series.
    Pepper DJ; Marais S; Maartens G; Rebe K; Morroni C; Rangaka MX; Oni T; Wilkinson RJ; Meintjes G
    Clin Infect Dis; 2009 Jun; 48(11):e96-107. PubMed ID: 19405867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors of paradoxical tuberculosis associated immune reconstitution inflammatory syndrome among HIV-infected patients in Beijing, China.
    Xue M; Xie R; Pang Y; Yan S; Du Y; Guan C; Chen B
    BMC Infect Dis; 2020 Jul; 20(1):554. PubMed ID: 32736608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.
    Naidoo K; Yende-Zuma N; Padayatchi N; Naidoo K; Jithoo N; Nair G; Bamber S; Gengiah S; El-Sadr WM; Friedland G; Abdool Karim S
    Ann Intern Med; 2012 Sep; 157(5):313-24. PubMed ID: 22944873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction.
    Narendran G; Andrade BB; Porter BO; Chandrasekhar C; Venkatesan P; Menon PA; Subramanian S; Anbalagan S; Bhavani KP; Sekar S; Padmapriyadarshini C; Kumar S; Ravichandran N; Raja K; Bhanu K; Mahilmaran A; Sekar L; Sher A; Sereti I; Swaminathan S
    PLoS One; 2013; 8(5):e63541. PubMed ID: 23691062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.
    Haddow LJ; Moosa MY; Mosam A; Moodley P; Parboosing R; Easterbrook PJ
    PLoS One; 2012; 7(11):e40623. PubMed ID: 23152745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of T-Lymphocyte Activation Related to Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in Persons With Advanced HIV.
    Tibúrcio R; Barreto-Duarte B; Naredren G; Queiroz ATL; Anbalagan S; Nayak K; Ravichandran N; Subramani R; Antonelli LRV; Satagopan K; Anbalagan K; Porter BO; Sher A; Swaminathan S; Sereti I; Andrade BB
    Front Immunol; 2021; 12():757843. PubMed ID: 34691079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune reconstitution inflammatory syndrome with tuberculosis: a common problem in Ethiopian HIV-infected patients beginning antiretroviral therapy.
    Ali K; Klotz SA
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(3):198-202. PubMed ID: 21521804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children.
    Van Rie A; Sawry S; Link-Gelles R; Madhi S; Fairlie L; Verwey C; Mahomed N; Murdoch D; Moultrie H
    Pediatr Pulmonol; 2016 Feb; 51(2):157-64. PubMed ID: 26073306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.
    Conesa-Botella A; Loembé MM; Manabe YC; Worodria W; Mazakpwe D; Luzinda K; Mayanja-Kizza H; Miri M; Mbabazi O; Koole O; Kestens L; Colebunders R;
    J Acquir Immune Defic Syndr; 2011 Dec; 58(5):463-8. PubMed ID: 21963941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.